Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:02 pm Sale | 2021-12-31 | 13G | MUDRICK CAP ACQUISITION CORP I MUDS | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,047,904 (Position Closed) | Filing History |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 2,455,536 7.400% | 35,381 (+1.46%) | Filing History |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | VIKING GLOBAL INVESTORS LP | 1,790,284 3.900% | -573,778 (-24.27%) | Filing History |
| 2022-02-14 5:01 pm Unchanged | 2021-12-31 | 13G | PROCEPT BIOROBOTICS CORP COM PRCT | VIKING GLOBAL INVESTORS LP | 4,907,892 11.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:01 pm Unchanged | 2021-12-31 | 13G | RALLYBIO CORP COM RLYB | VIKING GLOBAL INVESTORS LP | 524,347 13.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 88,238,700 12.800% | 88,238,700 (New Position) | Filing History |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | ZENTALIS PHARMACEUTICALS INC C ZNTL | VIKING GLOBAL INVESTORS LP | 2,118,284 4.700% | -893,000 (-29.66%) | Filing History |
| 2022-02-14 5:01 pm Unchanged | 2021-12-31 | 13G | TALARIS THERAPEUTICS INC TALS | VIKING GLOBAL INVESTORS LP | 328,962 8.000% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:01 pm Sale | 2021-12-31 | 13G | ABCELLERA BIOLOGICS INC. ABCL | VIKING GLOBAL INVESTORS LP | 0 0.000% | -19,283,744 (Position Closed) | Filing History |
| 2022-02-14 5:01 pm Purchase | 2021-12-31 | 13G | COUPA SOFTWARE INC COUP | VIKING GLOBAL INVESTORS LP | 4,168,030 5.600% | 322,311 (+8.38%) | Filing History |
| 2022-01-21 5:05 pm Purchase | 2022-01-11 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 7,170,536 12.400% | 7,170,536 (New Position) | Filing History |
| 2022-01-18 4:25 pm Purchase | 2022-01-06 | 13G | GUARDANT HEALTH INC GH | VIKING GLOBAL INVESTORS LP | 5,122,495 5.000% | 5,122,495 (New Position) | Filing History |
| 2022-01-05 5:29 pm Purchase | 2022-01-03 | 13G | API GROUP CORP COM APG | VIKING GLOBAL INVESTORS LP | 62,195,121 17.300% | 12,195,121 (+24.39%) | Filing History |